11 November

Kai's paper on the oncogenic function of MYBL2 in cutaneous melanoma was accepted for publication in Cancer Research. This tour-de-force study identifies an RNA binding function for the transcription factor MYBL2 that is gained in melanoma and possibly other cancers. RNA binding is required for its oncogenic potential and enables MYBL2 to induce chromatin accessibility changes, thereby promoting the oncogenic effects of other transcription factors, including MAFG and FRA1. Congratulations, Kai!

25 October

Florian joined the Executive Committee of the Society for Melanoma Research, taking on the role of Treasurer.

18 September

Florian traveled to Philadelphia to attend the CureOM meeting organized by the Melanoma Research Foundation and held at Jefferson University. Updates on preclinical and clinical aspects of melanoma research were provided by the excellent speakers.

31 August

Our manuscript comparing the oncogenic potential of the prevalent Q209L mutation with the rare Q209R mutation in GNAQ using uveal melanoma mouse models and cell lines was accepted for publication in Pigment Cell & Melanoma Research. Undergraduate student Vinesh is the first-author, while Xiaonan supervised the study and is co-corresponding author. Congratulations to everyone.

21 August

The lab was awarded a Bridge grant from the Bankhead-Coley Cancer Research Program of the Florida Department of Health. This will provide 6 months of support for our work on MAFG in melanoma.

18-22 August

Zulaida, Xiaonan, and Florian attended the Cold Spring Harbor Laboratory Models & Mechanisms of Cancer conference. Zulaida presented a talk on her finding that MAFG regulates HIF1A, while Xiaonan (uveal melanoma) and Florian (Nicol's work on circPMS1 in melanoma metastasis) presented posters.

 

20 July

Florian visited the Huntsman Cancer Institute at the University of Utah in Salt Lake City. He gave a seminar on the role of oncogenic transcription factors and their various functions in melanoma progression.

23 June

A meeting report of the 2025 CureOM meeting with Florian as co-author was published in Pigment Cell & Melanoma Research. This meeting was held in conjunction with the 2025 SMR congress in Amsterdam and discussed recent preclinical and clinical developments in the uveal melanoma field. Florian presented the lab's uveal melanoma genetically engineered mouse model at the meeting.

June 8

Arshia Mehta, a high school student from California, joins the lab for the summer as part of the MARCH program. She will be working with Shaaron on glycoRNAs. Welcome, Arshia.

26 May

The lab, together with the DeNicola lab, celebrated its 10th anniversary. We went to Universal Studios in Orlando for a day of fun!

May 22

Florian traveled to Madrid where he gave a seminar on the role of transcription factors in melanoma progression at the University Hospital La Paz. He was hosted by former postdoc Olga Vera who now leads her own research group at La Paz.

May 19

Anika Prasad, an undergraduate student from the University of Alabama at Birmingham, joins the lab for the summer as part of the 2026 Moffitt SPARK cohort. She will work with Zulaida on MAFG in melanoma progression. Welcome, Anika.

6-8 May

Florian traveled to Houston, TX, to attend a workshop organized by the Melanoma Academy of the DOD Melanoma Research PRogram. He presented the lab's work on glcyoRNAs.

May 1

Funding for our new NCI R01 began today. This award will support our work on the transcription factor MAFG and its role in melanoma phenotype switching and progression for the next five years.

5-6 March

The lab attended the Pan-American Society for Pigment Cell Research annual meeting, which Florian co-organized, in Ybor City, Tampa. Xiaonan, Zulaida, and Shaaron presented posters, and everybody made new friends and enjoyed the Tampa Harbor dinner cruise.

25-27 February

Florian, along with several other Moffitt melanoma faculty, attended the Melanoma Research Alliance annual retreat in Washington D.C. The melanoma community is as energized and vibrant as ever.

29 January

Another provisional paper acceptance, this time our study on the oncogenic activity of MAFG through its co-option of the MITF lineage transcription factor. This project took a village: Olga initiated the project, Michael continued it when Olga left, and Zulaida took it across the finish line after Michael left. Xiaonan, Kai, Nicol, and Harini also significantly contributed. Congratulations, everyone, on a nice story and getting this into Nature Communications.

11 January

Our manuscript describing the generation of a multi-step, immune competent genetically engineered mouse mode that closely recapitulates the progression of human uveal melanoma was accepted at Cancer Research. Xiaonan led this project and discovered phenotypic plasticity associated with aggressive, class 2 tumors. Congratulations, Xiaonan!